Publication | Closed Access

Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis

Glomerular DiseaseHypertensionRenal PathologyImmunologyRenal InflammationGlomerulonephritisRenal FunctionIga GlomerulonephritisPharmacologic ControlChronic Kidney DiseaseRenal PharmacologyPharmacologyRenal Tgf-betaUrologyRenal DiseaseAngiotensin IiMedicineNephrologyKidney Research